Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Torresan

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Oncology (Toronto, Ont.)|February 25, 2025
Oligometastatic NSCLC: Current Perspectives and Future ChallengesSara Torresan, Jacopo Costa, Carol Zanchetta, et al.
Current Problems in Diagnostic Radiology|July 12, 2023
Unveiling the Potential of Venn Diagrams as a Helpful Tool for Clinical Reasoning: An Illustrative Case-based DiscussionValeria Peruzzi, Sara Torresan, Francesco Cortiula, et al.
Journal of Clinical Medicine|February 25, 2023
Radiation Recall Pneumonitis Anticipates Bilateral Immune-Induced Pneumonitis in Non-Small Cell Lung CancerSara Torresan, Gaia Zussino, Francesco Cortiula, et al.
Cancers|May 14, 2025
Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Common Mutations: New StrategiesBrigida Stanzione, Alessandro Del Conte, Elisa Bertoli, et al.
International Journal of Molecular Sciences|January 25, 2025
Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung CancerSara Torresan, Martina Bortolot, Elisa De Carlo, et al.
International Journal of Molecular Sciences|December 17, 2024
Navigating Therapeutic Challenges in BRAF-Mutated NSCLC: Non-V600 Mutations, Immunotherapy, and Overcoming ResistanceMartina Bortolot, Sara Torresan, Elisa De Carlo, et al.
Critical Reviews in Oncology/Hematology|December 21, 2023
Liquid biopsy in colorectal cancer: Onward and upwardSara Torresan, Marco de Scordilli, Martina Bortolot, et al.
International Journal of Molecular Sciences|July 9, 2022
Immunotherapy in NSCLC Patients with Brain MetastasesSilvia Buriolla, Giacomo Pelizzari, Carla Corvaja, et al.
Frontiers in Oncology|April 2, 2026
BRAF class II-III mutations in NSCLC: a single center experienceSara Torresan, Martina Bortolot, Elisa Bertoli, et al.
International Journal of Molecular Sciences|January 25, 2025
Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic ApproachesLorenzo Foffano, Elisa Bertoli, Martina Bortolot, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Oncology (Toronto, Ont.)|February 25, 2025
Oligometastatic NSCLC: Current Perspectives and Future ChallengesSara Torresan, Jacopo Costa, Carol Zanchetta, et al.
Current Problems in Diagnostic Radiology|July 12, 2023
Unveiling the Potential of Venn Diagrams as a Helpful Tool for Clinical Reasoning: An Illustrative Case-based DiscussionValeria Peruzzi, Sara Torresan, Francesco Cortiula, et al.
Journal of Clinical Medicine|February 25, 2023
Radiation Recall Pneumonitis Anticipates Bilateral Immune-Induced Pneumonitis in Non-Small Cell Lung CancerSara Torresan, Gaia Zussino, Francesco Cortiula, et al.
Cancers|May 14, 2025
Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Common Mutations: New StrategiesBrigida Stanzione, Alessandro Del Conte, Elisa Bertoli, et al.
International Journal of Molecular Sciences|January 25, 2025
Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung CancerSara Torresan, Martina Bortolot, Elisa De Carlo, et al.
International Journal of Molecular Sciences|December 17, 2024
Navigating Therapeutic Challenges in BRAF-Mutated NSCLC: Non-V600 Mutations, Immunotherapy, and Overcoming ResistanceMartina Bortolot, Sara Torresan, Elisa De Carlo, et al.
Critical Reviews in Oncology/Hematology|December 21, 2023
Liquid biopsy in colorectal cancer: Onward and upwardSara Torresan, Marco de Scordilli, Martina Bortolot, et al.
International Journal of Molecular Sciences|July 9, 2022
Immunotherapy in NSCLC Patients with Brain MetastasesSilvia Buriolla, Giacomo Pelizzari, Carla Corvaja, et al.
Frontiers in Oncology|April 2, 2026
BRAF class II-III mutations in NSCLC: a single center experienceSara Torresan, Martina Bortolot, Elisa Bertoli, et al.
International Journal of Molecular Sciences|January 25, 2025
Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic ApproachesLorenzo Foffano, Elisa Bertoli, Martina Bortolot, et al.
Pageof 2